Skip to main content
Journal cover image

Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation.

Conferences
Hostetler, HP; Neely, ML; Lydon, E; Danziger-Isakov, LA; Todd, JL; Palmer, SM
Published in: Am J Transplant
August 2021

Vaccine-preventable viral infections are associated with increased risk of morbidity and mortality in post-transplant patients on immunosuppression regimens. Therefore, we studied rates of immunity against vaccine-preventable viruses in lung transplantation (LTx) candidates and their associations with underlying lung disease and clinical characteristics. We retrospectively studied 1025 consecutive adult patients who underwent first-time evaluation for LTx at a single center between January 2016 and October 2018. Viruses studied included varicella zoster (VZV), measles, and mumps. Young age (17-48 years old) was negatively associated with immunity for VZV (OR 4.54, p < .001), measles (OR 15.45, p < .001) and mumps (OR 3.1, p < .001), as compared to those 65+. Many LTx candidates with cystic fibrosis (CF) had undetectable virus-specific antibody titers including: 13.5% for VZV, 19.1% for measles, and 15.7% for mumps with significant odds of undetectable titers for VZV (OR 4.54, p < .001) and measles (OR 2.32, p = .010) as compared to those without CF. Therefore, a substantial number of patients undergoing LTx evaluation had undetectable virus-specific antibody titers. Our results emphasize the importance of screening for immunity to vaccine-preventable infections in this population and the need for revaccination in selected patients to boost their humoral immunity prior to transplantation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

August 2021

Volume

21

Issue

8

Start / End Page

2864 / 2870

Location

United States

Related Subject Headings

  • Young Adult
  • Surgery
  • Rubella
  • Retrospective Studies
  • Mumps
  • Middle Aged
  • Measles
  • Lung Transplantation
  • Humans
  • Chickenpox
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hostetler, H. P., Neely, M. L., Lydon, E., Danziger-Isakov, L. A., Todd, J. L., & Palmer, S. M. (2021). Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation. In Am J Transplant (Vol. 21, pp. 2864–2870). United States. https://doi.org/10.1111/ajt.16602
Hostetler, Haley P., Megan L. Neely, Elizabeth Lydon, Lara A. Danziger-Isakov, Jamie L. Todd, and Scott M. Palmer. “Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation.” In Am J Transplant, 21:2864–70, 2021. https://doi.org/10.1111/ajt.16602.
Hostetler HP, Neely ML, Lydon E, Danziger-Isakov LA, Todd JL, Palmer SM. Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation. In: Am J Transplant. 2021. p. 2864–70.
Hostetler, Haley P., et al. “Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation.” Am J Transplant, vol. 21, no. 8, 2021, pp. 2864–70. Pubmed, doi:10.1111/ajt.16602.
Hostetler HP, Neely ML, Lydon E, Danziger-Isakov LA, Todd JL, Palmer SM. Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation. Am J Transplant. 2021. p. 2864–2870.
Journal cover image

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

August 2021

Volume

21

Issue

8

Start / End Page

2864 / 2870

Location

United States

Related Subject Headings

  • Young Adult
  • Surgery
  • Rubella
  • Retrospective Studies
  • Mumps
  • Middle Aged
  • Measles
  • Lung Transplantation
  • Humans
  • Chickenpox